Research & Development | Corporate Development | Market Access | Patient Groups
What clinical trials and approval success is happening for orphan drugs? How is manufacturing requirements changing in the industry? We cover these topics and many more from both a pharma and biotech perspective.
Read more about our different streams including our manufacturing track to find out more.
How can industry gain an understanding of key orphan drug legislation and what incentives are available to developers of drugs which gain orphan designation? From reviewing the current pharmaceutical industry to discussing orphan drug development strategies, there’s lots to see and learn if you work in both corporate development for biotech and pharma.
What strategies are being used by industry to incentivise and reward innovation for niche therapies? Hear policy makers’ views on initiatives for orphan drug development and approval.
Develop your plan to improve stakeholder relations and effectively utilise patient groups by joining our Access and Pricing Track.